CooperVision International Limited (CVIL)

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, CooperVision International Limited (CVIL) sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 4 currently recruiting 5 completed top decile by trial count

CooperVision International Limited (CVIL): 11 sponsored US clinical trials, 4 recruiting.

CooperVision International Limited (CVIL) sponsors 11 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Myopia, with 3 trials.

Top-decile sponsor footprint

CooperVision International Limited (CVIL) ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

11 total, page 1 of 1

RECRUITING NA

Performance of Two Daily Disposable Multifocal Contact Lenses

NCT07444658
RECRUITING NA

Comprehensive Assessment of Multiple Products (CAMP)

NCT07276347
RECRUITING NA

A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

NCT06869044
RECRUITING

North American Comfilcon A Clinical Study

NCT06902584
NOT YET RECRUITING NA

Contact Lens Trial Fitting Experience

NCT07600645
NOT YET RECRUITING NA

Optimization for Toric Contact Lenses

NCT07557030
COMPLETED NA

Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types

NCT06232590
COMPLETED NA

Clinical Evaluation of Reusable Soft Contact Lenses

NCT06119191
COMPLETED NA

Performance Evaluation of Two Silicone Hydrogel Toric Lens Designs in Habitual Soft Contact Lens Wearers

NCT05933772
COMPLETED NA

Corneal Refractive Therapy Design Comparison for -4 to -6 Diopter Treatment for Overnight Wear for Myopia

NCT05438615
COMPLETED NA

High Refractive Index Material 510(k)

NCT00766168

Therapeutic Areas

Myopia 3
Presbyopia 2
Hyperopia 2
Ametropia 1
Astigmatism 1

What is open in the CooperVision International Limited (CVIL) pipeline

4 recruiting of 11 indexed (36% open); 5 completed (45%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Myopia (3 trials), 4 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

CooperVision International Limited (CVIL): open-pipeline peers nationwide

Peers matched on 11 registered trials and 36% open enrollment, not the therapeutic-area sidebar.

CooperVision International Limited (CVIL) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share CooperVision International Limited (CVIL)Aderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeStephanie B. Seminara, MDBioNTech SEMichael J. Fox Foundation for Parkinson's ResearchTrustees of Dartmouth College
CooperVision International Limited (CVIL) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

CooperVision International Limited (CVIL) sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 36% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this CooperVision International Limited (CVIL) page

11 registered trials is a research-attention snapshot, not an endorsement of CooperVision International Limited (CVIL) or any single study.

  • 4 of CooperVision International Limited (CVIL)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Myopia is the condition CooperVision International Limited (CVIL) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Myopia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

CooperVision International Limited (CVIL) pipeline card: 11 registered trials from official public datasets.Report a data error.